Early research (Phase 1)Study completedNCT05281263
What this trial is testing
Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults
Who this might be right for
Respiratory Syncytial Virus Infections
Blue Lake Biotechnology Inc. 30
Showing 20 of 52 results